SCHEMBL30107714

SCHEMBL30107714

c1ccc(-c2ccc3c(c2)c2cc(-c4ccccc4)ccc2n3-c2cc(-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)cc(-n3c4ccc(-c5ccccc5)cc4c4cc(-c5ccccc5)ccc43)c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 11/20 0.45
KMT2A Q03164 11/20 0.45
MAPT P10636 9/20 0.45
HPGD P15428 8/20 0.45
ALDH1A1 P00352 8/20 0.45
NTSR1 P30989 1/20 0.45
KDM4E B2RXH2 4/20 0.40
LMNA P02545 3/20 0.40
GLA P06280 1/20 0.40
ADORA2A P29274 2/20 0.39
ADORA1 P30542 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
NPSR1 Q6W5P4 2/20 0.38
RXFP1 Q9HBX9 1/20 0.38
CYP2C19 P33261 1/20 0.38
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
TDP1 Q9NUW8 2/20 0.36
CTRC Q99895 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30107851 1.00 MEN1 (0.45) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL30107738 0.97 MEN1 (0.43) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL25118625 0.97 MEN1 (0.45) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL30107760 0.96 MEN1 (0.42) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL29327989 0.96 MEN1 (0.42) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL30107852 0.96 MEN1 (0.42) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL30107904 0.96 MEN1 (0.47) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL9888887 0.96 MEN1 (0.47) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL30107722 0.93 MEN1 (0.40) MEN1KMT2AMAPTHPGDALDH1A1
SCHEMBL30107735 0.93 MEN1 (0.48) MEN1KMT2AMAPTHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11542260-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2023-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11542260-B2 Composition of matter for use in organic light-emitting diodes CRY2, NDUFV3, SLCO1B3 MEN1 3059/4885KMT2A 4205/4885MAPT 166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.